Literature DB >> 10328864

Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway.

H C Shin1, N Benbernou, S Esnault, M Guenounou.   

Abstract

In the present study, the authors compared the interleukin 17 (IL-17 expression of human naive and phenotypically defined memory T cells as well as its regulation by cAMP pathway. Our data showed that IL-17 mRNA was highly expressed in memory human peripheral CD8(+)45RO+T cells and CD4(+)45RO+T cells when peripheral blood mononuclear cells were first stimulated with ionomycin/PMA. IL-17 expression in memory CD8(+)T cells required accessory signals since culture of ionomycin/PMA-activated CD8(+)45RO+T cells alone did not result to IL-17 expression. In contrast, memory CD4(+)T cell population seems to be more independent. IL-17 and interferon gamma(IFN-gamma) mRNA were both inhibited in the presence of PGE2 or the cAMP analogue (dibutyryl-cAMP), while the anti-inflammatory cytokine IL-10 was highly increased. In contrast, naive CD45RA+T cells were unable to express IL-17 whatever the culture conditions. Naive CD4(+)and CD8(+)T cells were sensitive to the PKA regulatory pathway since they represent a significant source of IL-10 when PBMC were first cultured with ionomycin/PMA in the presence of either PGE2 or db-cAMP. The authors showed that naive cells are highly dependent to their microenvironment, since culture of ionomycin/PMA-activated CD45RA+T cells alone did not result in detectable levels of cytokines even in the presence of PGE2. Results also showed that PGE2 induced quite the same levels of intracellular cAMP in naive and memory cells suggesting that these cell populations are equally sensitive to PGE2. However, we suggest that PGE2 may be more efficient in blocking both IL-17 and IFN-gamma expression in already primed memory T cells, rather than in suppressing naive T cells that could represent a significant source of IL-10. Data suggest that PKA activation pathway plays a critical role in the regulation of cytokine profiles and consequently the functional properties of both human naive and memory CD4(+) and CD8(+)T cells during the immune and inflammatory processes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328864     DOI: 10.1006/cyto.1998.0433

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  34 in total

Review 1.  Regulation of epithelial cell functions by the intestinal milieu.

Authors:  Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

2.  Potentiation of Th17 cytokines in aging process contributes to the development of colitis.

Authors:  Xinshou Ouyang; Zhuoshun Yang; Ruihua Zhang; Paul Arnaboldi; Geming Lu; Qingshan Li; Weidong Wang; Biao Zhang; Miao Cui; Huafeng Zhang; Jane Liang-Chen; Lihui Qin; Feng Zheng; Bo Huang; Huabao Xiong
Journal:  Cell Immunol       Date:  2010-10-27       Impact factor: 4.868

3.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

Review 4.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

5.  Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection.

Authors:  Byung H Chung; Hye J Oh; Shang G Piao; Hyeon S Hwang; In O Sun; Sun R Choi; Hoon S Park; Bum S Choi; Yeong J Choi; Cheol W Park; Yong-Soo Kim; Mi-La Cho; Chul W Yang
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

Review 6.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

7.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

8.  Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells.

Authors:  A Andoh; H Takaya; J Makino; H Sato; S Bamba; Y Araki; K Hata; M Shimada; T Okuno; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

9.  Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.

Authors:  Yuhki Yagi; Akira Andoh; Osamu Inatomi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

10.  Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion.

Authors:  Carlo Chizzolini; Rachel Chicheportiche; Montserrat Alvarez; Casimir de Rham; Pascale Roux-Lombard; Sylvie Ferrari-Lacraz; Jean-Michel Dayer
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.